Pentax Medical Company Agrees to Pay $43 Million to Resolve Criminal Investigation Concerning Misbranded Endoscopes

FDA OCI, Pentax Medical, medical device, misbranded, endoscope, $43 million, criminal charges, revised cleaning instructions, FDA-cleared, reports, timely, drug-resistant bacteria, deferred prosecution agreement, DPA,
Source: Office of Criminal Investigations (OCI) Press Releases - Category: Medical Law Authors: Source Type: news